EGFR and breast carcinoma: Furthermore, overexpression of miR-338-3p reversed the stimulatory effect of EGFR on breast cancer cell proliferation (Supplementary Figure S5B), and the inhibitory effect of miR-338-3p on breast cancer cell proliferation could be rescued by EYA2 overexpression (Supplementary Figure S5C).